成熟的药物基因组因素带来了改进和成本效益
Joseph P Jarvis1, Scott E Megill1, Peter Silvester2
1Coriell Life Sciences, Philadelphia, PA, USA.
Cambridge prisms. Precision medicine
|March 29, 2024
概括
药物遗传学,使用遗传信息进行个性化医疗,面临的采用障碍,尽管证明了好处. 克服这些挑战是广泛临床整合和改善患者护理的关键.
科学领域:
- 基因组学和精准医学精准医学
- 临床药理学 临床药理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 人类基因组注释的进步承诺精准医学,使预测,诊断和治疗策略成为可能.
- 遗传信息的临床应用面临重大障碍,限制了广泛采用.
- 药物基因组学,利用遗传数据来确定药物的安全性和有效性,显示出早期采用,特别是在瘤学中.
研究的目的:
- 审查当前的药基因组测试技术和信息工具.
- 探索药物基因组学支持的医疗保健的价值驱动的实施策略.
- 通过SARS-CoV-2测试扩展的经验教训,提供对全球采用临界点的见解.
主要方法:
- 审查关于药物基因组测试技术和临床实用性的现有文献.
- 对大规模部署的实施策略和经济/临床结果的分析.
- 在SARS-CoV-2大流行期间从快速大批量测试中获得的案例研究见解.
主要成果:
- 尽管取得了进展,但基因组信息决策尚未成为大多数医疗保健系统的标准.
- 药基因组测试技术和决策支持工具正在进步,促进早期采用.
- 现实世界的数据表明,全面的药物基因组实施具有经济和临床的好处.
结论:
- 解决使用遗传信息的障碍对于实现精准医学的潜力至关重要.
- 有效的实施策略和先进的工具对于药物基因组学整合至关重要.
- 快速测试扩展的教训,就像在COVID-19大流行期间一样,为全球采用提供了途径.
相关概念视频
01:19Factors Affecting Drug Biotransformation: Biological
148
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
148
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
133
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
01:12Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
57
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
57